Why the power of CBDa actually starts with a low dose
Why the power of CBDa actually starts with a low dose
Anyone who delves into the world of cannabinoids will soon notice that most conversations revolve around CBD and THC. But according to Peter Vermeul, founder of CBD Spain and a long-time pioneer in the field of cannabinoid acids, one of the most interesting substances in the cannabis plant is still being underestimated: CBDa.
More and more research and practical experience indicate that the original acidic form of cannabidiol occupies a very distinct place within the natural composition of the hemp plant. Not only because of the unique properties of CBDa itself, but especially because of the way this substance works together with other natural components such as CBGa, CBCa, terpenes, flavonoids, and cannabflavins.
In his latest article, Peter Vermeul takes us through a topic that regularly raises questions among people looking for natural support for their health: why do low doses of a genuine Full Spectrum CBDa extract often seem to be so effective?
Back to the original plant
To understand why CBDa is so special, we must first return to nature itself.
What many people do not know is that the cannabis plant naturally produces almost no CBD. In a living plant, cannabinoid acids such as CBDa, CBGa, CBCa, and THCa are predominantly found. It is only through heating, prolonged storage, or processing that these compounds are converted into the well-known neutral cannabinoids such as CBD and THC.
According to Vermeul, this is precisely where a major difference lies. When the natural composition of the plant is preserved as much as possible, an extract is created that is closer to the plant's original profile. And that profile does not consist of a single active substance, but of hundreds of natural compounds that complement and influence each other.
This view aligns with what is often referred to as the entourage effect in the cannabinoid world: the idea that the power of the plant does not lie in a single molecule, but in the interaction between all the substances present.
Why more is not always better
In the conventional health world, we are accustomed to thinking that a higher dose automatically leads to a stronger effect. But with cannabinoids, reality often turns out to be more complex.
Peter Vermeul describes how, in practice, he repeatedly sees that people sometimes respond surprisingly well to very small amounts of a high-quality Full Spectrum CBDa extract. Not by flooding the body with high concentrations of a single substance, but by subtly introducing it to the complete plant profile.
This approach is known as microdosing.
Microdosing is not about using as much as possible. It is about careful observation, starting low, and listening to the body's response. This is precisely what creates space to support the body's natural balance without immediately administering large amounts of cannabinoids.
For many people, this approach feels intuitive and logical. Especially when they are looking for a gentle form of support alongside a healthy lifestyle or conventional treatment.
CBDa and medication: a nuanced story
One of the most frequently asked questions at CBD & Herb is whether Full Spectrum CBDa oil can be combined with conventional medication.
According to Peter Vermeul, this question deserves a nuanced answer. He emphasizes that not all cannabis products are the same. There is a major difference between a CBD isolate, a highly concentrated THC product, and an organically produced Full Spectrum CBDa extract in which the natural plant substances have been preserved.
Many warnings about possible interactions with medication are based on studies in which high doses of isolated CBD were used. According to Vermeul, this is not automatically comparable to the use of a microdose of a complete plant extract.
This does not mean, however, that caution is unnecessary. On the contrary. Precisely because everyone reacts differently, he advocates for transparency, product quality control, and cooperation with the treating physician when medication is being used.
The future of cannabinoid acids
While attention for many years was primarily focused on CBD and THC, researchers are increasingly shifting their interest toward cannabinoid acids such as CBDa and CBGa.
This is not surprising. After all, these compounds form the original building blocks that the plant itself produces. As more scientific knowledge becomes available, so too is the understanding that these substances may play a much more important role than was assumed for years.
For Peter Vermeul, this is no new discovery. For years, he has been committed to the development of pure organic Full Spectrum CBDa extracts in which the natural composition of the plant is preserved as much as possible. This vision also forms the basis of CBD Spain, of which CBD & Herb has been a distributor in Europe for many years.
Read Peter Vermeul's full article
The topic of microdosing with Full Spectrum CBDa oil touches on important questions about quality, dosage, safety, medication use, and the unique role of cannabinoid acids within the plant.
In this article, we have only lifted a corner of the veil. Do you want to read Peter Vermeul's full vision, including his extensive practical experience and explanation of why, according to him, low doses often yield the most interesting results?
Then read the complete article:
- Why the power of CBDa actually starts at a low dose - pdf NL
- Why the Power of CBDa actually starts at a Low dose - pdf EN
At CBD & Herb, we continue to collect the latest insights, research, and articles by Peter Vermeul, so that everyone has access to reliable information about the possibilities of Full Spectrum CBDa oil and natural support for health.
